Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2001
10/24/2001EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001EP1146790A1 Compounds and methods
10/24/2001EP0900190B1 Novel acetals of hydroxy carboxylic acids, derivatives thereof and process for the preparation thereof
10/24/2001EP0856002B1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
10/24/2001EP0822933B1 Process for producing piperidinopentanamines
10/24/2001CN1319091A Cyanophenyl derivatives
10/24/2001CN1319088A Arylsulfonanilide ureas
10/24/2001CN1319086A Anthranilic acid derivatives
10/24/2001CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001CN1073554C Process for preparation of o-chloromethyl-phenylglyoxylic acid derivatives
10/23/2001US6307087 Ligands for metals and improved metal-catalyzed processes based thereon
10/23/2001US6306959 Rapid purification by polymer supported quench
10/23/2001US6306859 Piperidine alkyl imides as neurotransmitters
10/23/2001US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/23/2001US6306854 Chemical compounds
10/23/2001US6306798 Compounds for controlling insects and representatives of the order acarina
10/23/2001CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/18/2001WO2001077101A1 Chemical compounds
10/18/2001WO2001077093A1 Estrogen agonist/antagonist metabolites
10/18/2001WO2001077069A1 Naphthamide neurokinin antagonists for use as medicaments
10/18/2001WO2000035436A3 Treatment of arthritis with mek inhibitors
10/18/2001US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
10/18/2001US20010031870 Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protese inhibitors
10/18/2001US20010031753 Process for the preparation of substituted benzophenones
10/18/2001US20010031730 Method for treatment of glutamate related disorders
10/18/2001CA2405070A1 Estrogen agonist/antagonist metabolites
10/18/2001CA2403012A1 Chemical compounds
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144370A2 Thyroid receptor ligands
10/17/2001EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144066A1 Dehydration process
10/17/2001EP1143960A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
10/17/2001EP1143957A2 Treatment of arthritis with mek inhibitors
10/17/2001EP0935486B1 Aqueous film-forming foam compositions
10/17/2001EP0833818B1 3-acylindoles as cb2 receptor agonists
10/17/2001CN1318050A Method for simulataneously producing cyclic lactam and cyclic amine
10/17/2001CN1073104C N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate
10/17/2001CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity
10/17/2001CN1073102C New 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications
10/17/2001CN1073101C Substituted 1,2,3,4-tetrahydronaphthalene derivatives
10/16/2001US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/16/2001US6303673 Photochromic compounds
10/16/2001US6303659 Administering adamantane derivative for therapy of rheumatoid arthritis
10/16/2001US6303656 For therapy and/or prophylaxis of human skin, mucous membranes and/or keratin fibers, in particular for moisturizing the skin and for treatment of dry skin
10/16/2001US6303612 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxphenylsulfanylarylacetic acids
10/16/2001US6303611 For therapy of hyperalgesis
10/16/2001US6303610 Method of treating gout with certain indole compounds
10/16/2001US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/11/2001WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074797A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands
10/11/2001WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/11/2001WO2000050376A9 Efficient synthesis of alkyl carbonates
10/11/2001WO2000017176A3 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
10/11/2001US20010029258 Partially saturated calcium channel blockers
10/11/2001CA2404475A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands
10/11/2001CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/11/2001CA2402705A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/10/2001EP1142862A2 Naphthyl and tetralone derivatives as intermediates
10/10/2001EP1140882A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
10/10/2001EP1140881A1 Antithrombotic amides
10/10/2001EP1140880A1 Homopiperazine derivatives as selective emopamil inhibitors
10/10/2001EP1140879A1 1-phenyl-4-(1- 2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands
10/10/2001EP1140878A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them ( inhibitio of factor xa activity )
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140846A1 Aspartic protease inhibitors
10/10/2001EP1140841A1 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same
10/10/2001EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
10/10/2001EP1140839A1 Heterocyclic amides as inhibitors of factor xa
10/10/2001EP1140837A1 Compounds useful in the treatment of inflammatory diseases
10/10/2001EP1140836A1 Amide compounds
10/10/2001EP1140829A1 Contrast media for angiography
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140810A1 Benzenic sulphonamide derivatives and their uses
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140807A1 Method for preparing nitroxides
10/10/2001EP1140803A1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140797A1 Production of acrylic monomers
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140745A1 Colchinol derivatives as vascular damaging agents
10/10/2001EP1140067A1 Antiviral method using mek inhibitors
10/10/2001EP1140066A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
10/10/2001EP1140046A1 Use of a mek inhibitor for preventing transplant rejection
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001CN1316996A Method for joint production of cyclic lactam and cyclic amine
10/10/2001CN1316990A Methoximinophenylacetic acid amides
10/10/2001CN1316419A Arenesulfonyl amino-iso hydroximic acid derivative
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/10/2001CN1072663C Novel benzoyl guanidine derivatives, process for their preparation and thier use in the preparation of medicines
10/10/2001CN1072662C Phenyl alkyl ketone substituted by cyclic amine and process for preparation thereof
10/10/2001CN1072661C Novel substituted [2-(1-piperazinyl)ethyoxy] methyl compound
10/10/2001CN1072642C Butanedioic acid derivative and their use as surfactants
10/09/2001US6300499 α1-adrenergic receptor antagonists
10/09/2001US6300368 Anilide derivatives and antiarrhythmic agents containing the same
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 341